While high expression levels of RAC1 became evident in neoplastic breast tissue of ductal carcinoma-in-situ, primary breast cancer, and lymph node metastases—with low levels in benign breast tissue, little if any differences in expression levels of RAC1B were reported in benign and malignant breast tissue [3]. This evidence concerns the gene RAC1 and breast carcinoma.